# U.S. FDA issues four observations to Gland Pharma formulation facility near Hyderabad — retained record

> Retained news record from news:india-hindu-business.

Canonical: https://highsignal.app/data/records/6608397af9858a26

[← sources](https://highsignal.app/data)


source: [news](https://highsignal.app/data/news) (news:india-hindu-business)  published 2026-10-24 05:38 ingested 2026-10-24 15:22

[original source ↗](https://www.thehindu.com/business/Industry/us-fda-issues-four-observations-to-gland-pharma-formulation-facility-near-hyderabad/article71616791.ece)

## retained text



```
The four Form 483 observations followed an unannounced inspection on current good manufacturing practice at the facility in Dundigal between October 12 and 23
```



document fetched 2026-10-24 15:22 · canonical https://thehindu.com/business/Industry/us-fda-issues-four-observations-to-gland-pharma-formulation-facility-near-hyderabad/article71616791.ece